We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Should Allow Reciprocal Approval for Generic Drugs to Reduce Prices, Increase Availability
FDA Should Allow Reciprocal Approval for Generic Drugs to Reduce Prices, Increase Availability
The FDA could offset drug price spikes or shortages by allowing reciprocal approvals for certain generic drugs with limited competition, according to joint research from Johns Hopkins, Yale, Harvard and the Council on Foreign Relations, published in BMJ.